ORGANIZE ME!

Senator Cardin (D-MD) proposed to dramatically scale back individual and corporate income taxes and finance that cut with his Progressive Consumption Tax.

Jeffrey Janus, the Director, Senior Vice President Operations ISCO; CEO of Lifeline Cell Technolog of International Stem Cell Corp, made $578,258 in total compensation during 2011, according to salary benchmarking data.

Jeffrey Janus, the Director, Senior Vice President Operations ISCO; CEO of Lifeline Cell Technolog of International Stem Cell Corp, made $578,258 in total compensation during 2011, according to salary benchmarking data.

Search Engine Land is the leading industry source for daily, must-read news and in-depth analysis about search engine marketing.

The latest Tweets from Jeffrey Janus MD (@JeffreyJanusMD). Chair @MayoClinic ENT Jacksonville Florida|Physician|Head and Neck Cancer Surgeon|Dad|tweets are my own. Jacksonville Beach, FL

The latest Tweets from Jeffrey Janus MD (@JeffreyJanusMD). Chair @MayoClinic ENT Jacksonville Florida|Physician|Head and Neck Cancer Surgeon|Dad|tweets are my own. Jacksonville Beach, FL

Even though dysfunctional emotion regulation is prominent in depression and a link between depression and inflammation is well established, there is little knowledge about how inflammation affects the regulation of emotions. The aim of this pilot study was to explore the effect of experimentally ind …

This study proposes using thermal plasma technology to treat municipal solid waste incinerator ashes. A feasible fiberization method was developed and applied to produce man-made vitreous fiber (MMVF) from plasma vitrified slag. MMVF were obtained through directly blending the oxide melt stream with …

We are healthcare professionals seeking talented individuals to join our dynamic team and grow with us on the path to success.

We are healthcare professionals seeking talented individuals to join our dynamic team and grow with us on the path to success.

Mr. Janus was formally the Chief Executive Officer of ES Cell International Pte Ltd and led the ESI BIO Research Products Division at BioTime Inc. before joining Asc..

Mr. Janus was formally the Chief Executive Officer of ES Cell International Pte Ltd and led the ESI BIO Research Products Division at BioTime Inc. before joining Asc..

Researchers from Oceanside CA-based International Stem Cell Corporation, a publicly traded stem cell therapy company, (ISCO.OB), have recently published two papers illustrating two different techniques that lead to the creation of human parthenogenetic stem cells by stimulating unfertilized eggs. One technique leads to “patient-matched” parthenogenetic stem cells that are immune matched to the egg donor. The second technique leads to stem cells that can be immune-matched to large segments of the human population (called “HLA-homozygous”). Both research papers are published online in the journal Cloning and Stem Cells. According to Sir Ian Wilmut, the creator of the first cloned animal (Dolly the sheep), “Immune reaction is one of the most serious problems facing the development of stem cell therapy, and cell lines of this type may enable us to treat a large number of patients without immune rejection, offering an enormous practical advantage.”

Researchers from Oceanside CA-based International Stem Cell Corporation, a publicly traded stem cell therapy company, (ISCO.OB), have recently published two papers illustrating two different techniques that lead to the creation of human parthenogenetic stem cells by stimulating unfertilized eggs. One technique leads to “patient-matched” parthenogenetic stem cells that are immune matched to the egg donor. The second technique leads to stem cells that can be immune-matched to large segments of the human population (called “HLA-homozygous”). Both research papers are published online in the journal Cloning and Stem Cells. According to Sir Ian Wilmut, the creator of the first cloned animal (Dolly the sheep), “Immune reaction is one of the most serious problems facing the development of stem cell therapy, and cell lines of this type may enable us to treat a large number of patients without immune rejection, offering an enormous practical advantage.”

An important issue in the health care sector is the collection of information about adverse incidents relative to medical devices and the exchange of this information among Health Care Institutions, Manufacturers and Competent Authorities. We present an Electronic Post Market Surveillance System, wh …

Since 2012 six AAL pilot regions were launched in Austria. The main goal of these pilot regions is to evaluate the impact of AAL technologies in daily use considering the entire value chain. Additionally, go-to market strategies for assistive technologies based on an involvement of all relevant stak …